drugset / Trial / NCT00172419
The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients.
Completed
43 enrolled
National Taiwan University Hospital
National Science and Technology Council, Taiwan · collabPfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
Inflammation is important in the both pathogenesis and outcome of atherosclerosis. Plaques containing numerous inflammatory cells, particular macrophages, have a high risk of rupture.We hypothesize that statin-induced plaque regression could be monitored clinically by use of FDG PET/CT approach, and can be detected noninvasively earlier than previously reported.
Timeline
- Start
- 2007-03
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | — |